multifactorial risk scores have been developed to predict outcome after cardiac surgery. [7] [8] [9] [10] [11] [12] Although most of the score systems were designed to predict mortality, postoperative morbidity and length of hospital stay have been recognized as major determinants of both hospital cost and quality of life after surgery. 13 In 1995, Tu and colleagues developed a simple six-variable risk index to predict mortality, length of intensive care unit (ICU) stay and postoperative length of stay after cardiac surgery. 11 However, these additive risk models were developed outside of Asia and have never been validated in Taiwan. Our study is the first to apply these risk stratification models (Parsonnet score and Tu score) to a Taiwan population who received cardiac surgery to predict mortality, morbidity and likelihood of prolonged ICU stay. Furthermore, we compared the performance of logistic regression models developed from our population to the performance of the Parsonnet score and Tu score.
Materials and Methods

Data collection
After receiving approval from our local institutional ethics committee, we retrospectively studied 622 adult patients who received cardiac surgery during a 2-year period (from August 1, 2004 to August 31, 2006) at Taichung Veterans General Hospital. Because our study entailed no intervention in patient care, we were allowed to waive written informed consent. Patients who underwent cardiac transplantation and operation for congenital heart disease were excluded due to the small number of cases. Charts were reviewed by two anesthesiologists and preoperative patient characteristics were recorded. Data collected included age, gender, body height, body weight, left ventricular ejection fraction (LVEF), serum creatinine level, priority of surgery (emergency, defined as surgery within 24 hours after cardiac catheterization; urgent, defined as diagnosis and surgery in the same admission), surgical procedure, prior cardiac surgery, dyspnea class (New York Heart Association [NYHA]), and various pre-existing conditions: previous myocardial infarction (MI), intra-aortic balloon pump (IABP) before operation, cerebrovascular disease, hypertension (defined as blood pressure above 160 mmHg systolic or 90 mmHg diastolic or active treatment for hypertension), ventricular aneurysm, pulmonary hypertension (defined as systolic pulmonary artery pressure above 60 mmHg), aorto-ventricular pressure gradient, chronic obstructive pulmonary disease (COPD), diabetes mellitus (DM), dialysis dependency, catastrophic states (e.g. acute structural defect, cardiogenic shock and acute renal failure) and other rare circumstance (e.g. paraplegia, pacemaker dependency and severe asthma).
Outcomes
The main outcomes of our study included inhospital mortality, major postoperative morbidity and prolonged postoperative length of ICU stay. In-hospital mortality was defined as death occurring during hospital stay. Prolonged length of ICU stay was defined as a stay of more than 6 days. Major morbidity was defined using criteria previously reported by Dupuis et al, and described below.
14 Cardiovascular: low cardiac output, hypotension, or both, treated with IABP, with two or more intravenous inotropes or vasopressors for more than 24 hours, or with both; malignant arrhythmia (asystole and ventricular tachycardia or fibrillation) requiring cardiopulmonary resuscitation, anti-arrhythmia therapy, or automatic cardiodefibrillator implantation.
Respiratory: mechanical ventilation for more than 48 hours, tracheostomy, re-intubation.
Neurologic: focal brain injury with permanent functional deficits, irreversible encephalopathy.
Renal: acute renal failure requiring dialysis. Infection: septic shock with positive blood cultures, deep sterna or wound infection requiring intravenous antibiotics, surgical debridement, or both.
Other: any surgery or invasive procedure necessary to treat a postoperative adverse event associated with the initial cardiac surgery.
Risk stratification of patients
In the current study, patients were divided into a reference set and a validation set. One third of all patients were randomly assigned to the reference set (n = 199), and the rest of the study population assigned to the validation set (n = 423). Multifactorial risk scores were determined for each patient according to the risk indexes developed for general cardiac surgical populations by Parsonnet et al and Tu et al ( Table 1 ). The Parsonnet score and Tu score were calibrated separately with the reference set according to the outcomes of mortality, morbidity and prolonged ICU stay. Logistic regression models the probability of an event occurring as a linear function of a set of predictor variables. The actual state of the dependent variable is determined by looking at the estimated probability. Preoperative patient characteristics were used to build the logistic regression models. All predictors were chosen by fitting a logistic regression using a stepwise forward selection procedure (p < 0.05 to enter). We developed a separate logistic regression model for each of the three outcomes by using the reference set. The validation set was subjected to the Parsonnet score, Tu score and logistic regression. 
Statistical analysis
Predictions were made with the validation set using the Parsonnet score, Tu score and logistic regression. Accuracy (number of correct predictions divided by the total number of predictions), sensitivity, specificity, and likelihood ratios for positive and negative predictions of the Parsonnet score, Tu score and logistic regression were determined by statistical analysis using the SAS software (SAS Inc., Cary, NC, USA). The discriminating power of these prediction models can be determined by measuring the receiver operating characteristic (ROC) curves. ROC analysis estimates a curve that describes the inherent tradeoff between sensitivity and specificity of a prediction tool. Discriminatory power is measured by the area under the ROC curve (AUC). AUC is a particularly important metric for evaluating prediction tools because it is the average sensitivity over all possible specificities. AUC may range from 0 to 1, with an area of 1 representing perfect discrimination and an area of 0.5 representing that expected by chance alone. In this study, a criterion (cut-off) value corresponding to the highest accuracy (minimal false-negative and false-positive results) was selected to report the sensitivity and specificity of each prediction tool.
Results
A total of 622 patients receiving cardiac surgery during a 2-year period were retrospectively studied. The characteristics of these patients are presented in Table 2 . The in-hospital mortality and major morbidity rates in the reference group (n = 423) were 10.9% and 52.0%, respectively. Comparable patient characteristics, mortality (10.6%) and morbidity (50.8%) rates were found in the validation group (n = 199). The mean postoperative length of ICU stay was 6.6 ± 9.8 days with a median of 3 days in the reference population, and 7.3 ± 9.8 days in the validation group with a median of 4 days. Incidence of prolonged ICU stay was 20.6% and 21.6% in the reference and validation sets, respectively. The overall in-hospital mortality rate, major morbidity rate and incidence of prolonged ICU stay were 10.8%, 51.6% and 20.9%, respectively. Table 3 shows the preoperative variables of the reference group in relation to in-hospital mortality, major morbidity and prolonged length of ICU stay by univariate analysis. Variables included age, LVEF, dialysis dependency, surgical procedure, priority of the surgery, prior cardiac surgery, preoperative cardiogenic shock, dyspnea class (NYHA), preoperative IABP use, hypertension, LV aneurysm, pulmonary hypertension, aorto-ventricular pressure, DM, catastrophic state and rare circumstance. All except age, female gender, cerebrovascular disease, pulmonary hypertension and COPD were statistically significant (p < 0.05) predictors of in-hospital mortality. Age, LVEF, dialysis dependency, complexity of surgical procedure, priority of the surgery, congestive heart failure (NYHA), preoperative IABP use, cerebrovascular disease, hypertension, COPD, DM, catastrophic states and rare circumstance were statistically significant predictors (p < 0.05) of major morbidity. Comparably, age, complexity of surgical procedure, priority of surgery, congestive heart failure (NYHA), preoperative IABP use, cerebrovascular disease, COPD, catastrophic states and rare circumstance were statistically significant in predicting prolonged ICU stay (p < 0.05). Table 4 shows the ability of the Parsonnet score, Tu score and logistic regression models to predict the three outcomes in the validation set. The overall accuracy of the Parsonnet score, Tu score and logistic regression was 74.9%, 75.9% and 88.9% in predicting in-hospital mortality; sensitivity was 76.2%, 71.4% and 81.0%, and specificity was 74.7%, 76.4% and 89.9%. The accuracy of the Parsonnet score, Tu score and logistic regression in predicting major morbidity was 68.8%, 68.8% and 74.9%; sensitivity was 49.5%, 81.2% and 69.3%; and specificity was 88.8%, 56.1% and 80.6%. The accuracy of the Parsonnet score, Tu score and logistic regression in predicting prolonged ICU stay was 70.9%, 63.3% and 75.4%; sensitivity was 48.8%, 69.8% and 60.5%; and specificity was 76.9%, 61.5% and 80.1%.
The AUC of the Parsonnet score, Tu score and logistic regression in predicting in-hospital mortality was 0.843, 0.714 and 0.867 (Figure 1 ). The AUC of the Parsonnet score, Tu score and logistic regression in predicting major morbidity was 0.784, 0.736 and 0.808 (Figure 2 ). The AUC of the Parsonnet score, Tu score and logistic regression in predicting prolonged ICU stay was 0.701, 0.689 and 0.764 (Figure 3) . The discriminating powers of these models were compared using pair-wise analysis of the ROC curves (Table 5) . We found no statistically significant differences between the Parsonnet score and logistic regression in predicting in-hospital mortality, major morbidity and prolonged ICU stay. The Parsonnet score and logistic regression performed significantly better than the Tu score in predicting in-hospital mortality (p < 0.05). There were no statistically significant commonly used by anesthesiologists and surgeons such as the Goldman index, the Acute Physiology and Chronic Health Evaluation (APACHE) score and the American Society of Anesthesiologists (ASA) health status classification were not specially designed for cardiac surgery. Therefore, an accurate and objective evaluation tool for assessing perioperative risk for cardiac surgery has important consequences for patients, physicians and administrators.
Although mortality has been referred to as the most important performance indicator in cardiac surgery, and is the most frequently reported outcome parameter in evaluating risk scores, other outcomes like major morbidity and duration of ICU stay can profoundly influence both health care cost and quality of life. 8, 11, 12, 16 Our study underlines the applicability of risk stratification models for assessing in-hospital mortality, major morbidity and prolonged ICU stay after cardiac surgery. We selected the Parsonnet score and Tu score for validation since the variables used by these two models were routinely and completely recorded in our database. Our study had some limitations. Because the databases for the Parsonnet score and the Tu score are now more than 10 years old, their predictive value may be lessened by intervening advances in surgical and medical therapy. In addition, there were only three identical risk factors (age, catastrophic state, rare circumstance) in the logistic regression models. Since morbidity and length of ICU stay are comprised of parameters as heterogeneous as the need for mechanical ventilation support or re-operation for bleeding, the weight of certain risk factors may be different and must be adjusted according to different outcomes. For these reasons, predicting models will need to be calibrated and predicted risk adjusted before these results can have clinical application.
In our study population, 39.5% of patients were aged 75 years or older, 14.3% had poor left ventricular function (LVEF < 30%), 22% underwent complex surgery, and 27.2% received emergency or urgent surgery. These factors are known to be important risk factors for mortality and morbidity in cardiac surgery. 6, 11, [17] [18] [19] [20] These may explain why the in-hospital mortality and major morbidity rates in our study were obviously higher than previous studies. Nevertheless, the performance of the Parsonnet score and the Tu score in our study were comparable to that of previous reports. 6, 11 Our study used models which limited the predicting variables to those known before the operation occurred. In fact, some factors such as surgical technique, quality of care, echocardiographic and catheterization data related to the severity of cardiac disease, extracorporeal circulation time, therapeutic interventions and chance occurrences not related to preoperative patient characteristics (e.g. surgical error or medical error), may also influence the outcomes of cardiac surgery. 21, 22 It is impossible to include all of these variables in a model for preoperative risk stratification, although their inclusion may improve predictions. In summary, development of risk prediction models is essential for risk assessment, cost-benefit analysis, comparison of quality between institutions or individuals, and the study of therapy trends. 6, [23] [24] [25] An ideal model should be accurate, objective and easy to use. In our study, the Parsonnet score performed as well as the logistic regression models in predicting in-hospital mortality, major morbidity and likelihood of ICU stay.
Although logistic regression models have the highest discriminating power in predicting in-hospital mortality, major morbidity and likelihood of prolonged ICU stay among tested models, they are too complex for clinical use and require the use of a computer to calculate probability. Unlike the logistic regression model, the risk index of the Parsonnet score and the Tu score were created by rounding the mean of the odds ratios that are calculated from the coefficients of the variables in the logistic regression models for each risk factor to the nearest integer. On the other hand, the Tu score is a simple tool for risk assessment, but its discriminating power is not satisfying. The Parsonnet score appears to be a very suitable model for clinicians to use in risk stratification of cardiac surgery, possessing both power and ease of use. Finally, it should always be remembered that the predicted probability calculated from these models reflects only the likelihood of adverse events with average care by an average surgeon, and must be interpreted cautiously. 
